Identification of novel genetic etiology and key molecular pathways for seminoma via network-based studies

Chen,Yuanlei; Qi,Chao; Xia,Liqun; Li,Gonghui

doi:10.3892/ijo.2017.4092

Identification of novel genetic etiology and key molecular pathways for seminoma via network-based studies

Authors:
- Yuanlei Chen
- Chao Qi
- Liqun Xia
- Gonghui Li
View Affiliations

Affiliations: Department of Urology and Chawnshang Chang Liver Cancer Center, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China, Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China
Published online on: August 4, 2017 https://doi.org/10.3892/ijo.2017.4092
Pages: 1280-1290

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Seminoma is the most common testicular malignant germ cell tumor which severely threaten male reproductive health. However, the pathogenesis and progression mechanisms are still unclear and little research is carried out to uncover the mechanism of this cancer. To identify gene signatures that are expected to converge on particular molecular pathways may drive the development of the core cancer characteristics in seminoma. We downloaded the gene expression profiles GSE18155 from GEO database and obtained the differentially expressed genes (DEGs). Then, we performed Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes pathway (KEGG) enrichment analyses via DAVID. In total, 3,502 DEGs were identified, including 1,563 upregulated genes and 1,939 downregulated genes. The top 10 hub genes, Ubc, Ubb, Mapk8, Ar, Pten, Cdk2, Cdk4, Rac1, Top2a and Cdkn1a were identified from the protein-protein interaction (PPI) network which was constructed by Cytoscape. Sub-networks analyzed by MCODE plugin revealed these genes were involved in significant molecular pathways, including ERBB2 signaling pathway, pathways in cancer, PI3K‑AKT signaling pathway and cell cycle. Finally, validation of hub genes was checked via reverse transcription-polymerase chain reaction (RT-PCR) assay and immunohistochemistry (IHC). In conclusion, our study revealed that the identified hub genes increased the understanding of genetic etiology and molecular mechanisms underlying the development of seminoma, in return, they could be used as potential diagnostic biomarkers and therapeutic molecular targets for seminoma.

View Figures

View References

1	Manku G, Hueso A, Brimo F, Chan P, Gonzalez-Peramato P, Jabado N, Gayden T, Bourgey M, Riazalhosseini Y and Culty M: Changes in the expression profiles of claudins during gonocyte differentiation and in seminomas. Andrology. 4:95–110. 2016. View Article : Google Scholar
2	Litchfield K, Summersgill B, Yost S, Sultana R, Labreche K, Dudakia D, Renwick A, Seal S, Al-Saadi R, Broderick P, et al: Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours. Nat Commun. 6:59732015. View Article : Google Scholar : PubMed/NCBI
3	Aran V, Victorino AP, Thuler LC and Ferreira CG: Colorectal cancer: Epidemiology, disease mechanisms and interventions to reduce onset and mortality. Clin Colorectal Cancer. 15:195–203. 2016. View Article : Google Scholar : PubMed/NCBI
4	Taylor-Weiner A, Zack T, O'Donnell E, Guerriero JL, Bernard B, Reddy A, Han GC, AlDubayan S, Amin-Mansour A, Schumacher SE, et al: Genomic evolution and chemoresistance in germ-cell tumours. Nature. 540:114–118. 2016. View Article : Google Scholar : PubMed/NCBI
5	Liu T, Li R, Zhao H, Deng J, Long Y, Shuai MT, Li Q, Gu H, Chen YQ and Leng AM: eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma. Oncotarget. 7:66851–66864. 2016. View Article : Google Scholar : PubMed/NCBI
6	Chieffi P and Chieffi S: Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumors: An overview. J Cell Physiol. 228:1641–1646. 2013. View Article : Google Scholar : PubMed/NCBI
7	Trabert B, Chen J, Devesa SS, Bray F and McGlynn KA: International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973–2007. Andrology. 3:4–12. 2015. View Article : Google Scholar
8	Gilligan TD, Seidenfeld J, Basch EM, Einhorn LH, Fancher T, Smith DC, Stephenson AJ, Vaughn DJ, Cosby R and Hayes DF; American Society of Clinical Oncology: American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors. J Clin Oncol. 28:3388–3404. 2010. View Article : Google Scholar : PubMed/NCBI
9	Murray MJ, Huddart RA and Coleman N: The present and future of serum diagnostic tests for testicular germ cell tumours. Nat Rev Urol. 13:715–725. 2016. View Article : Google Scholar : PubMed/NCBI
10	Hanna NH and Einhorn LH: Testicular cancer - discoveries and updates. N Engl J Med. 371:2005–2016. 2014. View Article : Google Scholar : PubMed/NCBI
11	Sheikine Y, Genega E, Melamed J, Lee P, Reuter VE and Ye H: Molecular genetics of testicular germ cell tumors. Am J Cancer Res. 2:153–167. 2012.
12	Kanetsky PA, Mitra N, Vardhanabhuti S, Li M, Vaughn DJ, Letrero R, Ciosek SL, Doody DR, Smith LM, Weaver J, et al: Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet. 41:811–815. 2009. View Article : Google Scholar : PubMed/NCBI
13	Rijlaarsdam MA and Looijenga LH: An oncofetal and developmental perspective on testicular germ cell cancer. Semin Cancer Biol. 29:59–74. 2014. View Article : Google Scholar : PubMed/NCBI
14	Huang W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar
15	Consortium TGO: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium Nat Genet. 25:25–29. 2000.
16	Ogata H, Goto S, Sato K, Fujibuchi W, Bono H and Kanehisa M: KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 27:29–34. 1999. View Article : Google Scholar
17	Köhler S, Bauer S, Horn D and Robinson PN: Walking the interactome for prioritization of candidate disease genes. Am J Hum Genet. 82:949–958. 2008. View Article : Google Scholar : PubMed/NCBI
18	Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB and McGlynn KA: International trends in the incidence of testicular cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev. 19:1151–1159. 2010. View Article : Google Scholar : PubMed/NCBI
19	Cook MB, Akre O, Forman D, Madigan MP, Richiardi L and McGlynn KA: A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer - experiences of the son. Int J Epidemiol. 39:1605–1618. 2010. View Article : Google Scholar : PubMed/NCBI
20	Peng J, Wu Y, Tian X, Pang J, Kuai L, Cao F, Qin X, Zhong J, Li X, Li Y, et al: High-throughput sequencing and co-expression network analysis of lncRNAs and mRNAs in early brain injury following experimental subarachnoid haemorrhage. Sci Rep. 7:465772017. View Article : Google Scholar : PubMed/NCBI
21	Jain A, Tripathi R, Turpin CP, Wang C and Plattner R: Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanoma. Oncogene. Apr 3–2017.Epub ahead of print. View Article : Google Scholar : 2017.
22	Chen L, Fu H, Luo Y, Chen L, Cheng R, Zhang N and Guo H: cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling. Cell Death Dis. 8:e27282017. View Article : Google Scholar
23	Liu N, Mei L, Fan X, Tang C, Ji X, Hu X, Shi W, Qian Y, Hussain M, Wu J, et al: Phosphodiesterase 5/protein kinase G signal governs stemness of prostate cancer stem cells through Hippo pathway. Cancer Lett. 378:38–50. 2016. View Article : Google Scholar : PubMed/NCBI
24	Perez R, Wu N, Klipfel AA and Beart RW Jr: A better cell cycle target for gene therapy of colorectal cancer: Cyclin G. J Gastrointest Surg. 7:884–889. 2003. View Article : Google Scholar : PubMed/NCBI
25	Tominaga O1, Nita ME, Nagawa H, Fujii S, Tsuruo T and Muto T: Expressions of cell cycle regulators in human colorectal cancer cell lines. Jpn J Cancer Res. 88:855–860. 1997. View Article : Google Scholar : PubMed/NCBI
26	Shen HQ, Xiao YX, She ZY, Tan FQ and Yang WX: A novel role of KIF3b in the seminoma cell cycle. Exp Cell Res. 352:95–103. 2017. View Article : Google Scholar : PubMed/NCBI
27	Sherr CJ, Beach D and Shapiro GI: Targeting CDK4 and CDK6: From discovery to therapy. Cancer Discov. 6:353–367. 2016. View Article : Google Scholar :
28	Asghar U, Witkiewicz AK, Turner NC and Knudsen ES: The history and future of targeting cyclin-dependent kinases in cancer therapy. Nat Rev Drug Discov. 14:130–146. 2015. View Article : Google Scholar : PubMed/NCBI
29	Oury F, Sumara G, Sumara O, Ferron M, Chang H, Smith CE, Hermo L, Suarez S, Roth BL, Ducy P, et al: Endocrine regulation of male fertility by the skeleton. Cell. 144:796–809. 2011. View Article : Google Scholar : PubMed/NCBI
30	Rao PM, Kelly DM and Jones TH: Testosterone and insulin resistance in the metabolic syndrome and T2DM in men. Nat Rev Endocrinol. 9:479–493. 2013. View Article : Google Scholar : PubMed/NCBI
31	Qi J, Tripathi M, Mishra R, Sahgal N, Fazli L, Ettinger S, Placzek WJ, Claps G, Chung LW, Bowtell D, et al: The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity. Cancer Cell. 23:332–346. 2013. View Article : Google Scholar : PubMed/NCBI
32	Ito S, Ueda T, Ueno A, Nakagawa H, Taniguchi H, Hongo F, Kamoi K, Okihara K, Kawauchi A and Miki T: Paired box 2 upregulates androgen receptor gene expression in androgen-independent prostate cancer. FEBS J. 281:4506–4518. 2014. View Article : Google Scholar : PubMed/NCBI
33	Wang RS, Yeh S, Tzeng CR and Chang C: Androgen receptor roles in spermatogenesis and fertility: Lessons from testicular cell-specific androgen receptor knockout mice. Endocr Rev. 30:119–132. 2009. View Article : Google Scholar : PubMed/NCBI
34	Nakagawa H, Ueda T, Ito S, Shiraishi T, Taniguchi H, Kayukawa N, Nakanishi H, Ushijima S, Kanazawa M, Nakamura T, et al: Androgen suppresses testicular cancer cell growth in vitro and in vivo. Oncotarget. 7:35224–35232. 2016. View Article : Google Scholar : PubMed/NCBI
35	Di Vizio D, Cito L, Boccia A, Chieffi P, Insabato L, Pettinato G, Motti ML, Schepis F, D'Amico W, Fabiani F, et al: Loss of the tumor suppressor gene PTEN marks the transition from intra-tubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. Oncogene. 24:1882–1894. 2005. View Article : Google Scholar : PubMed/NCBI
36	McIver SC, Stanger SJ, Santarelli DM, Roman SD, Nixon B and McLaughlin EA: A unique combination of male germ cell miRNAs coordinates gonocyte differentiation. PLoS One. 7:e355532012. View Article : Google Scholar : PubMed/NCBI
37	Gilbert DC, McIntyre A, Summersgill B, Missiaglia E, Goddard NC, Chandler I, Huddart RA and Shipley J: Minimum regions of genomic imbalance in stage I testicular embryonal carcinoma and association of 22q loss with relapse. Genes Chromosomes Cancer. 50:186–195. 2011. View Article : Google Scholar : PubMed/NCBI
38	Wu P, Tian Y, Chen G, Wang B, Gui L, Xi L, Ma X, Fang Y, Zhu T, Wang D, et al: Ubiquitin B: An essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells. Cell Death Differ. 17:109–118. 2010. View Article : Google Scholar
39	Nenoi M: Induced accumulation of polyubiquitin gene transcripts in HeLa cells after UV-irradiation and TPA-treatment. Int J Radiat Biol. 61:205–211. 1992. View Article : Google Scholar : PubMed/NCBI
40	Finch JS, St John T, Krieg P, Bonham K, Smith HT, Fried VA and Bowden GT: Overexpression of three ubiquitin genes in mouse epidermal tumors is associated with enhanced cellular proliferation and stress. Cell Growth Differ. 3:269–278. 1992.PubMed/NCBI
41	Ryu KY, Sinnar SA, Reinholdt LG, Vaccari S, Hall S, Garcia MA, Zaitseva TS, Bouley DM, Boekelheide K, Handel MA, et al: The mouse polyubiquitin gene Ubb is essential for meiotic progression. Mol Cell Biol. 28:1136–1146. 2008. View Article : Google Scholar :
42	Ciechanover A and Schwartz AL: The ubiquitin system: Pathogenesis of human diseases and drug targeting. Biochim Biophys Acta. 1695:3–17. 2004. View Article : Google Scholar : PubMed/NCBI
43	Hoeller D and Dikic I: Targeting the ubiquitin system in cancer therapy. Nature. 458:438–444. 2009. View Article : Google Scholar : PubMed/NCBI